Literature DB >> 11108274

The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase.

C Buettner1, J W Harney, P R Larsen.   

Abstract

Human type 2 iodothyronine deiodinase (hD2) catalyzes the activation of T4 to T3. D2, like types 1 and 3 deiodinases, contains selenocysteine (Sec) in the highly conserved active center at position 133. To evaluate the contribution of Sec133 to the catalytic properties of hD2, we generated mutants in which cysteine (Cys) or alanine (Ala) replaced Sec133. The Km (T4) of Cys133D2 was 2.1 microM, strikingly higher than that of native D2 (1.4 nM). In contrast, the relative turnover number was 10-fold lower for Cys133D2, illustrating the greater potency of Se than S in supporting catalysis. The AlaD2 mutant was inactive. Studies in intact cells transiently expressing the native or Cys133D2 enzyme exhibited saturation kinetics expected from the Km as measured under in vitro conditions, indicating rapid equilibration of extracellular and intracellular T4. Blockade of the NTCP, OATP1-3, and LST-1 transporters with 10 mM sodium taurocholate did not alter the deiodination rate of T4 by Cys133D2 transiently expressed in intact cells, suggesting that intracellular transport of T4 is not rate limiting. These results illustrate that selenium plays a critical role in deiodination catalyzed by hD2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108274     DOI: 10.1210/endo.141.12.7831

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

2.  Characterization of circRNA-Associated-ceRNA Networks in a Senescence-Accelerated Mouse Prone 8 Brain.

Authors:  Shuai Zhang; Dina Zhu; Hong Li; Hejian Li; Chengqiang Feng; Wensheng Zhang
Journal:  Mol Ther       Date:  2017-06-29       Impact factor: 11.454

3.  Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.

Authors:  Jennifer H Olker; Joseph J Korte; Jeffrey S Denny; Phillip C Hartig; Mary C Cardon; Carsten N Knutsen; Paige M Kent; Jessica P Christensen; Sigmund J Degitz; Michael W Hornung
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice.

Authors:  Christoph Buettner; Rima Patel; Evan D Muse; Sanjay Bhanot; Brett P Monia; Rob McKay; Silvana Obici; Luciano Rossetti
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.

Authors:  Ana Luiza Maia; Brian W Kim; Stephen A Huang; John W Harney; P Reed Larsen
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

6.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

Review 7.  Selenocysteine, pyrrolysine, and the unique energy metabolism of methanogenic archaea.

Authors:  Michael Rother; Joseph A Krzycki
Journal:  Archaea       Date:  2010-08-17       Impact factor: 3.273

8.  Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China.

Authors:  T-W Guo; F-C Zhang; M-S Yang; X-C Gao; L Bian; S-W Duan; Z-J Zheng; J-J Gao; H Wang; R-L Li; G-Y Feng; D St Clair; L He
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

9.  Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.

Authors:  Guoying Yu; Argyris Tzouvelekis; Rong Wang; Jose D Herazo-Maya; Gabriel H Ibarra; Anup Srivastava; Joao Pedro Werneck de Castro; Giuseppe DeIuliis; Farida Ahangari; Tony Woolard; Nachelle Aurelien; Rafael Arrojo E Drigo; Ye Gan; Morven Graham; Xinran Liu; Robert J Homer; Thomas S Scanlan; Praveen Mannam; Patty J Lee; Erica L Herzog; Antonio C Bianco; Naftali Kaminski
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.